Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Geroscience ; 39(5-6): 499-550, 2017 12.
Article in English | MEDLINE | ID: mdl-29270905

ABSTRACT

A paradox is a seemingly absurd or impossible concept, proposition, or theory that is often difficult to understand or explain, sometimes apparently self-contradictory, and yet ultimately correct or true. How is it possible, for example, that oxygen "a toxic environmental poison" could be also indispensable for life (Beckman and Ames Physiol Rev 78(2):547-81, 1998; Stadtman and Berlett Chem Res Toxicol 10(5):485-94, 1997)?: the so-called Oxygen Paradox (Davies and Ursini 1995; Davies Biochem Soc Symp 61:1-31, 1995). How can French people apparently disregard the rule that high dietary intakes of cholesterol and saturated fats (e.g., cheese and paté) will result in an early death from cardiovascular diseases (Renaud and de Lorgeril Lancet 339(8808):1523-6, 1992; Catalgol et al. Front Pharmacol 3:141, 2012; Eisenberg et al. Nat Med 22(12):1428-1438, 2016)?: the so-called, French Paradox. Doubtless, the truth is not a duality and epistemological bias probably generates apparently self-contradictory conclusions. Perhaps nowhere in biology are there so many apparently contradictory views, and even experimental results, affecting human physiology and pathology as in the fields of free radicals and oxidative stress, antioxidants, foods and drinks, and dietary recommendations; this is particularly true when issues such as disease-susceptibility or avoidance, "healthspan," "lifespan," and ageing are involved. Consider, for example, the apparently paradoxical observation that treatment with low doses of a substance that is toxic at high concentrations may actually induce transient adaptations that protect against a subsequent exposure to the same (or similar) toxin. This particular paradox is now mechanistically explained as "Adaptive Homeostasis" (Davies Mol Asp Med 49:1-7, 2016; Pomatto et al. 2017a; Lomeli et al. Clin Sci (Lond) 131(21):2573-2599, 2017; Pomatto and Davies 2017); the non-damaging process by which an apparent toxicant can activate biological signal transduction pathways to increase expression of protective genes, by mechanisms that are completely different from those by which the same agent induces toxicity at high concentrations. In this review, we explore the influences and effects of paradoxes such as the Oxygen Paradox and the French Paradox on the etiology, progression, and outcomes of many of the major human age-related diseases, as well as the basic biological phenomenon of ageing itself.


Subject(s)
Adaptation, Physiological , Aging/genetics , Diet, High-Protein/statistics & numerical data , Hypercholesterolemia/epidemiology , Oxidative Stress/physiology , Oxygen/metabolism , Aged , Aged, 80 and over , Aging/physiology , Female , France , Free Radicals/metabolism , Geriatric Assessment , Humans , Male , Middle Aged , Risk Assessment
2.
Biometals ; 18(6): 567-75, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16388396

ABSTRACT

Iron overload aggravates tissue damage caused by ischemia and ethanol intoxication. The underlying mechanisms of this phenomenon are not yet clear. To clarify these mechanisms we followed free iron ("loosely" bound redox-active iron) concentration in livers from rats subjected to experimental iron overload, acute ethanol intoxication, and ex vivo warm ischemia. The levels of free iron in non-homogenized liver tissues, liver homogenates, and hepatocyte cultures were analyzed by means of EPR spectroscopy. Ischemia gradually increased the levels of endogenous free iron in liver tissues and in liver homogenates. The increase was accompanied by the accumulation of lipid peroxidation products. Iron overload alone, known to increase significantly the total tissue iron, did not affect either free iron levels or lipid peroxidation. Homogenization of iron-loaded livers, however, resulted in the release of a significant portion of free iron from endogenous depositories. Acute ethanol intoxication increased free iron levels in liver tissue and diminished the portion of free iron releasing during homogenization. Similarly to liver tissue, the primary hepatocyte culture loaded with iron in vitro released significantly more free iron during homogenization compared to non iron-loaded hepatocyte culture. Analyzing three possible sources of free iron release under these experimental conditions in liver cells, namely ferritin, intracellular transferrin-receptor complex and heme oxygenase, we suggest that redox active free iron is released from ferritin under ischemic conditions whereas ethanol and homogenization facilitate the release of iron from endosomes containing transferrin-receptor complexes.


Subject(s)
Ethanol/administration & dosage , Iron Overload/metabolism , Iron/metabolism , Ischemia/metabolism , Animals , Cells, Cultured , Diet , Disease Models, Animal , Electron Spin Resonance Spectroscopy , Female , Hepatocytes/metabolism , Hepatocytes/pathology , Injections, Intraperitoneal , Iron Overload/pathology , Ischemia/pathology , Liver/blood supply , Liver/metabolism , Liver/pathology , Rats , Rats, Wistar
3.
Free Radic Biol Med ; 34(10): 1283-94, 2003 May 15.
Article in English | MEDLINE | ID: mdl-12726916

ABSTRACT

Various drugs and chemicals can cause a glutathione (GSH) depletion in the liver. Moreover, nitric oxide (NO) can be generated in response to physiological and pathological situations such as inflammation. The aim of this study was to estimate oxidative stress when primary rat hepatocytes were exposed to GSH depletion after NO production. For this purpose, cells were preincubated with lipopolysaccharide (LPS) and gamma-interferon (IFN) for 18 h in order to induce NO production by NO synthase and then L-buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, was added for 5 h. In hepatocyte cultures preincubated with LPS and IFN before BSO addition, an increase in lipid peroxidation was noted. In those cells, an elevation of iron-bound NO and a decrease in free NO led us to suggest the involvement of low-molecular-weight iron (LMW iron) in the enhancement of oxidative stress. Indeed, addition of deferiprone, a chelator of LMW iron, reduced iron-bound NO levels and the extent of oxidative stress. Moreover, an important elevation of LMW iron levels was also observed. As both, N-acetylcysteine, a GSH precursor, and N(G)-monomethyl-L-arginine, a NO synthase inhibitor, totally inhibited the elevation of LMW iron and oxidative stress, a cooperative role could be attributed to NO production and GSH depletion.


Subject(s)
Buthionine Sulfoximine/pharmacology , Glutathione/deficiency , Hepatocytes/drug effects , Iron/metabolism , Nitric Oxide/biosynthesis , Oxidative Stress , Acetylcysteine/pharmacology , Animals , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Deferiprone , Ditiocarb/pharmacology , Electron Spin Resonance Spectroscopy , Enzyme Inhibitors/pharmacology , Hepatocytes/metabolism , Interferon-gamma/pharmacology , Iron Chelating Agents/pharmacology , Lipid Peroxidation/drug effects , Lipopolysaccharides/pharmacology , Liver/drug effects , Liver/metabolism , Nitric Oxide Synthase/metabolism , Nitrites/metabolism , Nitrites/pharmacology , Pyridones/pharmacology , Rats , Rats, Sprague-Dawley , omega-N-Methylarginine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...